Literature DB >> 21165808

Walking ability and all-cause mortality in older women.

S Mutikainen1, T Rantanen, M Alén, M Kauppinen, J Karjalainen, J Kaprio, U M Kujala.   

Abstract

In this study self-reported ability to walk 2 km and six-minute walking test (6MWT) performance were examined as predictors of all-cause mortality in 434 women, aged 63-76 years. The primary outcome measure was all-cause mortality (follow-up: 8 years). Predictors were self-reported difficulties in walking 2 km and 6-min walking distance tertiles of ≤495, 496-560 and ≥561 m, and no test result due to refusal by the physician to grant permission to perform the test or participant's inability or unwillingness to perform the test. During the follow-up, 39 participants died. Participants reporting minor (age- and body mass index-adjusted hazard ratio 2.53, 95% confidence interval 1.12-5.69) or major (7.93, 3.49-18.05) difficulties in walking 2 km had increased risk of death compared with those reporting no difficulties. Participants with no 6MWT result (6.99, 2.46-19.86) were at an increased risk of death when compared with participants who walked ≥561 m. A similar trend (2.47, 0.81-7.56) was found for participants with walking distance of ≤495 m during the 6MWT. The trends remained similar after adjustments for other confounders. In conclusion, self-reported difficulties in walking 2 km are associated with an increased risk of death in older community-dwelling women. Objectively measured walking ability gives similar results. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 21165808     DOI: 10.1055/s-0030-1268506

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  9 in total

1.  The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

Authors:  Peter J Snyder; Susan S Ellenberg; Glenn R Cunningham; Alvin M Matsumoto; Shalender Bhasin; Elizabeth Barrett-Connor; Thomas M Gill; John T Farrar; David Cella; Raymond C Rosen; Susan M Resnick; Ronald S Swerdloff; Jane A Cauley; Denise Cifelli; Laura Fluharty; Marco Pahor; Kristine E Ensrud; Cora E Lewis; Mark E Molitch; Jill P Crandall; Christina Wang; Matthew J Budoff; Nanette K Wenger; Emile R Mohler; Diane E Bild; Nakela L Cook; Tony M Keaveny; David L Kopperdahl; David Lee; Ann V Schwartz; Thomas W Storer; William B Ershler; Cindy N Roy; Leslie J Raffel; Sergei Romashkan; Evan Hadley
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

2.  Recruitment and Screening for the Testosterone Trials.

Authors:  Jane A Cauley; Laura Fluharty; Susan S Ellenberg; Thomas M Gill; Kristine E Ensrud; Elizabeth Barrett-Connor; Denise Cifelli; Glenn R Cunningham; Alvin M Matsumoto; Shalender Bhasin; Marco Pahor; John T Farrar; David Cella; Raymond C Rosen; Susan M Resnick; Ronald S Swerdloff; Cora E Lewis; Mark E Molitch; Jill P Crandall; Alisa J Stephens-Shields; Thomas W Strorer; Christina Wang; Stephen Anton; Shehzad Basaria; Susan Diem; Vafa Tabatabaie; Darlene Dougar; Xiaoling Hou; Peter J Snyder
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-15       Impact factor: 6.053

3.  Sarcopenia with limited mobility: an international consensus.

Authors:  John E Morley; Angela Marie Abbatecola; Josep M Argiles; Vickie Baracos; Juergen Bauer; Shalender Bhasin; Tommy Cederholm; Andrew J Stewart Coats; Steven R Cummings; William J Evans; Kenneth Fearon; Luigi Ferrucci; Roger A Fielding; Jack M Guralnik; Tamara B Harris; Akio Inui; Kamyar Kalantar-Zadeh; Bridget-Anne Kirwan; Giovanni Mantovani; Maurizio Muscaritoli; Anne B Newman; Filippo Rossi-Fanelli; Giuseppe M C Rosano; Ronenn Roubenoff; Morris Schambelan; Gerald H Sokol; Thomas W Storer; Bruno Vellas; Stephan von Haehling; Shing-Shing Yeh; Stefan D Anker
Journal:  J Am Med Dir Assoc       Date:  2011-07       Impact factor: 4.669

4.  PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.

Authors:  M Cesari; R Fielding; O Bénichou; R Bernabei; S Bhasin; J M Guralnik; A Jette; F Landi; M Pahor; L Rodriguez-Manas; Y Rolland; R Roubenoff; A J Sinclair; S Studenski; T Travison; B Vellas
Journal:  J Frailty Aging       Date:  2015

5.  Association Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease.

Authors:  Ali Yazdanyar; Michael M Aziz; Paul L Enright; Daniel Edmundowicz; Robert Boudreau; Kim Sutton-Tyrell; Lewis Kuller; Anne B Newman
Journal:  J Aging Health       Date:  2014-04-02

6.  Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients.

Authors:  Esther Martín-Ponce; Iván Hernández-Betancor; Emilio González-Reimers; Rubén Hernández-Luis; Antonio Martínez-Riera; Francisco Santolaria
Journal:  Sci Rep       Date:  2014-12-22       Impact factor: 4.379

7.  Muscle Synergies Facilitate Computational Prediction of Subject-Specific Walking Motions.

Authors:  Andrew J Meyer; Ilan Eskinazi; Jennifer N Jackson; Anil V Rao; Carolynn Patten; Benjamin J Fregly
Journal:  Front Bioeng Biotechnol       Date:  2016-10-13

8.  Computational Design of FastFES Treatment to Improve Propulsive Force Symmetry During Post-stroke Gait: A Feasibility Study.

Authors:  Nathan R Sauder; Andrew J Meyer; Jessica L Allen; Lena H Ting; Trisha M Kesar; Benjamin J Fregly
Journal:  Front Neurorobot       Date:  2019-10-01       Impact factor: 2.650

9.  Environmental barriers, person-environment fit and mortality among community-dwelling very old people.

Authors:  Merja Rantakokko; Timo Törmäkangas; Taina Rantanen; Maria Haak; Susanne Iwarsson
Journal:  BMC Public Health       Date:  2013-08-28       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.